Twain Therapeutics
Chemicals & Related Products · 1-10 Employees
View Company Info for Free
Overview
Website
www.twaintherapeutics.comRevenue
<$5 MillionIndustry
About Twain Therapeutics
Twain Therapeutics Org Chart
Is Twain Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Twain Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Twain Therapeutics recently announced quarterly report
Funding: Get notified immidiatlly once Twain Therapeutics has new funding data
Congratulate Masked Content for being promoted to Masked Content at Twain Therapeutics
Twain Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Twain Therapeutics launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Twain Therapeutics is spiking on competitors!
Click to see if Twain Therapeutics had a recent Job posting/layoffs
Recommended Actions
Find VP level buyers at Twain Therapeutics
Find 2 more new buyers
Company Profile Activity
Activity Insights
Twain Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Twain Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Twain Therapeutics.
Top Chemicals & Related Products Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Twain Therapeutics
Twain Therapeutics specializes in multi-specific biologics aimed at treating cancer and autoimmune diseases. The company leverages common gamma chain biology to enhance the efficacy of its products, which feature an extended half-life and are administered subcutaneously. Their innovative approach targets both oncology and immunology markets. Intend... Read More